{"ok":true,"entity":{"id":"bfarm","name":"BfArM (Federal Institute for Drugs and Medical Devices)","entityType":"organization","officialName":"Bundesinstitut für Arzneimittel und Medizinprodukte（BfArM）","canonicalName":"BfArM (Federal Institute for Drugs and Medical Devices)","displayName":"BfArM (Federal Institute for Drugs and Medical Devices)","category":"ドイツの医薬品・医療機器規制当局（連邦上級官庁）","shortDescription":"BfArM（連邦医薬品医療機器研究所）は、ドイツ連邦保健省の所管下にある独立した連邦上級官庁で、ボンとケルンに拠点を置き、約1,350人が勤務する。医薬品の承認、医薬品の安全性向上、医療機器のリスクの検出・評価、麻薬の合法的な取引の監視を担う。ワクチンや血液製剤などを主に所管するPaul-Ehrlich-Instituteとは別の連邦上級官庁である（医薬品法上の所管分担による）。","primaryCluster":"pharmaceuticals","parentEntity":null,"verificationStatus":"draft","website":"https://www.bfarm.de/EN/BfArM/_node.html","updatedAt":"2026-10-29T04:31:31.488Z","secondaryClusters":[],"alias":["BfArM","Bundesinstitut für Arzneimittel und Medizinprodukte","Federal Institute for Drugs and Medical Devices","ドイツ連邦医薬品医療機器研究所"],"searchKeywords":["ビーエフアーム","BfArM","連邦医薬品医療機器研究所","ドイツ 医薬品規制","ボン","Arzneimittelgesetz","national competent authority","Paul-Ehrlich-Institut","医療機器 リスク評価","麻薬 監視"]},"referenceIndex":["P-01-001","P-02-001","P-04-001","P-05-001","P-06-001"]}